The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients.

MLA

Fariña-Sarasqueta, A., et al. “The BRAF V600E Mutation Is an Independent Prognostic Factor for Survival in Stage II and Stage III Colon Cancer Patients.” Annals of Oncology, vol. 21, no. 12, Dec. 2010, pp. 2396–402. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=55533622&authtype=sso&custid=ns315887.

APA

Fariña-Sarasqueta, A., van Lijnschoten, G., Moerland, E., Creemers, G.-J., Lemmens, V. E. P. P., Rutten, H. J. T., & van den Brule, A. J. C. (2010). The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients. Annals of Oncology, 21(12), 2396–2402.

Chicago

Fariña-Sarasqueta, A., G. van Lijnschoten, E. Moerland, G.-J. Creemers, V. E. P. P. Lemmens, H. J. T. Rutten, and A. J. C. van den Brule. 2010. “The BRAF V600E Mutation Is an Independent Prognostic Factor for Survival in Stage II and Stage III Colon Cancer Patients.” Annals of Oncology 21 (12): 2396–2402. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=55533622&authtype=sso&custid=ns315887.